Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Por um escritor misterioso
Descrição
Combination immunotherapy shrinks metastatic brain cancer
Double Trouble: Immunotherapy Doublets in Melanoma—Approved and Novel Combinations to Optimize Treatment in Advanced Melanoma
Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients
First-Line Nivolumab/Ipilimumab Yields Durable Survival Benefit in Asymptomatic Melanoma With Brain Mets
Ipilimumab plus nivolumab in patients with symptomatic melanoma brain metastasis requiring corticosteroids - ScienceDirect
1694-Melanoma metastatic ipilimumab and nivolumab (induction)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Cureus, Aggressive Stereotactic Radiosurgery Coupled With Immune and Targeted Therapy for Recurrent Melanoma Brain Metastases: A Case Report and Literature Review
Efficacy and Safety of Immune Checkpoint Inhibitors for Advanced Malignant Melanoma: A Meta-Analysis on Monotherapy Vs Combination Therapy
Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature - Yolanda Piña, Brittany R. Evernden, Nikhil Khushalani, Kim Margolin, Hussein
Evolving impact of long-term survival results on metastatic melanoma treatment
Ipilimumab (Yervoy) Drug Information
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons. - Document - Gale OneFile: Health and Medicine
Nivolumab and Relatlimab for Advanced Melanoma - NCI
Nivolumab (Opdivo) Drug Information
de
por adulto (o preço varia de acordo com o tamanho do grupo)
